Evidence map›Paper›PMID 35685453›Full record

ArticleAdvances in pharmacological and pharmaceutical sciences2022

Angela Fonseca-Benitez, Sandra Johanna Morantes Medina, Diego Ballesteros-Vivas, Fabian Parada-Alfonso, Sandra J Perdomo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in pharmacological and pharmaceutical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Angela Fonseca-BenitezCell and Molecular Immunology Group, Universidad El Bosque INMUBO, Bogotá D.C., Colombia.
Sandra Johanna Morantes MedinaGrupo de Investigación en Química Aplicada-INQA, Programa Química Farmacéutica Universidad El Bosque, Bogotá D.C., Colombia.ORCID https://orcid.org/0000-0002-7780-2066
Diego Ballesteros-VivasDepartamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D.C., Colombia.ORCID https://orcid.org/0000-0001-7286-3735
Fabian Parada-AlfonsoFood Chemistry Research Group, High Pressure Laboratory, Departamento de Química. Departamento de Química, Facultad de Ciencias, Universidad Nacional de Colombia, Bogotá D.C., Colombia.ORCID https://orcid.org/0000-0003-0896-4114
Sandra J PerdomoCell and Molecular Immunology Group, Universidad El Bosque INMUBO, Bogotá D.C., Colombia.ORCID https://orcid.org/0000-0002-4429-3760
Universidad El Bosque · COPontificia Universidad Javeriana · COUniversidad Nacional de Colombia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multicellular tumor spheroids are used as models in drug development due to their characteristics simulating in vivo tumors. Likewise, antiproliferative properties of extracts derived from fruits have been widely described. Peels and seeds can be used as a matrix to obtain different compounds. Recently, a study demonstrated the antiproliferative activity from a

Identifiers

PMID35685453
PMCPMC9174002
OpenAlexW4281992303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.